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Abstract
Diarrhea after bariatric procedures, mainly those with 
malabsorptive elements including Roux-Y Gastric 
Bypass and Biliopancreatic Diversion, is common and 
an essential determinant of quality of life and micro- 
and macronutrient deficiencies. Bariatric surgery is 
the only sustainably successful method to address 
morbid obesity and its comorbidities, particularly 
gaining more and more importance in the specific 
treatment of diabetic patients. Approximately half a 
million procedures are annually performed around 
the world, with numbers expected to rise drastically 
in the near future. A multitude of factors exert their 
influence on bowel habits; preoperative comorbidities 
and procedure-related aspects are intertwined with 
postoperative nutritional habits. Diagnosis may be 
challenging owing to the characteristics of post-
bariatric surgery anatomy with hindered accessibility of 
excluded segments of the small bowel and restriction 
at the gastric level. Conventional testing measures, if 
available, generally yield low accuracy and are usually 
not validated in this specific population. Limited trials 
of empiric treatment are a practical alternative and 
oftentimes an indispensable part of the diagnostic 
process. This review provides an overview of causes 
for chronic post-bariatric surgery diarrhea and details 
the particularities of its diagnosis and treatment in this 
specific patient population. Topics of current interest 
such as the impact of gut microbiota and the influence 
of bile acids on morbid obesity and especially their role 
in diarrhea are highlighted in order to provide a better 
understanding of the specific problems and chances of 
future treatment in post-bariatric surgery patients.
Key words: Bariatric surgery; Diarrhea; Malnutrition; 
Malabsorption; Steatorrhea; Dumping syndrome; Bile 
acids and salts; Gut microbiota; Blind loop syndrome
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Core tip: Bariatric surgery is the only sustainable 
therapy for morbid obesity and its comorbidities. 
Postoperative diarrhea is common and an essential 
determinant of quality of life and micro- and macro-
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nutrient deficiencies. The distinctive anatomic changes 
after bariatric procedures with exclusion of various 
length of small bowel have a severe impact not only on 
diagnostic but also puts limits on therapeutic means. 
This review provides an overview of causes for chronic 
diarrhea in the particular context of post-bariatric 
patients, and details specific problems in diagnosis and 
treatment of this challenging patient population.
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INTRODUCTION
Bariatric surgery was demonstrated to be the most 
efficacious method to achieve sustainable weight 
loss and resolution of co-morbidities among the 
morbidly obese. Roux-en-Y gastric bypass (RYGB), 
sleeve gastrectomy (SG) and to a lesser extent bilio-
pancreatic diversion with duodenal switch (BPD-DS) 
are the most commonly applied procedures (Figure 
1). Around 470000 bariatric procedures have been 
performed worldwide in 2013, with numbers expected 
to rise in the future as the threshold, currently at a 
body mass index of 35 kg/m2, will be lowered to 30 
kg/m2 in diabetic patients[1-4]. Weight loss is achieved 
by different mechanisms, all having various effects on 
bowel habits. The implied alterations of the anatomy 
not only affect the sensitivity and specificity of diag–
nostic procedures but also the pharmacodynamics 
and bioavailability of the used medication, potentially 
resulting in treatment failure[5]. 
Bariatric surgery, especially BPD-DS and distal 
RYGB, leads to a significant change of bowel habits 
with enhanced frequency of malodorous flatus and 
diarrhea[6]. Diarrhea exposes patients at risk for fecal 
incontinence - up to 50% of patients after BPD-DS are 
affected - and has a major impact on Quality of Life 
as well as on nutrient and vitamin absorption[7-9]. In 
addition, morbid obesity per se, and in particular its 
associated comorbidities, broadens the spectrum of 
possible causes for diarrhea. 
The goal of this review is to detail causes for chronic 
diarrhea in the specific post-bariatric surgery context, 
especially after RYGB, and to give a focused overview 
of its diagnosis and treatment, with the intention to 
depict the differences and difficulties compared to an 
evaluation for diarrhea in non-operated patients[10-12]. 
Reasons nonspecific for post-bariatric surgery patients, 
such as cancer-related diarrhea, are not covered, even 
though the incidence of cancer is higher in the bariatric 
than in the non-obese population[13]. 
EATING HABITS AND LIFESTYLE 
CHANGES 
Bariatric surgery results in a radical change of life with 
lifestyle modifications eventually resulting in change of 
food preference, meal size and frequency. The imposed 
restriction, especially in the earlier postoperative 
period, leads to a more liquid diet with decreased fiber 
intake[14]. While adaptive processes towards a stable 
metabolism and energy intake take at least 1 year[15], 
patients rarely benefit from an extensive evaluation 
prior to 6 mo postoperatively. 
There are inconsistent data about postoperative 
food consumption, mainly because of self-reporting, 
incongruent assessment time points, changing food 
selection over time, and influence of nutritional 
counselling[16]. Overall energy intake is reduced after 
surgery; however, the proportion of fat, proteins 
and carbohydrates seems to remain constant[17]. In 
our practice, we observe an increased consumption 
of dietary and fat-reduced products in a purpose to 
eat “healthier”. However, the use of non-absorbable 
sweeteners such as sorbitol in these products can lead 
to similar effects as carbohydrate malabsorption[18].
BARIATRIC PROCEDURES
SG
Sleeve gastrectomy has become the most popular 
bariatric procedure in the last years. The greater 
curvature of the stomach is resected alongside a 
bougie preserving around 5 cm of antrum (Figure 1).
Proximal and distal RYGB
RYGB was the most popular procedure for years. A 
small gastric pouch is created followed by a pouch-
jejunostomy, thereby forming an alimentary Roux-Y 
limb of up to 150 cm and a biliopancreatic limb of 
around 50 cm resulting in a common channel of various 
lengths depending on the length of whole small bowel. 
In distal RYGB, the length of the common channel, 
mostly around 100 cm, is the determined factor and the 
alimentary limb is of variable length (Figures 2 and 3). 
BPD-DS
The gastric volume is reduced akin to a LSG but 
with a generally bigger bougie size. The duodenum 
is transected near the pylorus and a duodeno-
jejunostomy is created to form a common channel of 
around 80 cm.
Adjustable gastric banding
Adjustable gastric banding (AGB) experienced a massive 
decline in the past decade due to a failure of long-
term weight loss. Currently it is used almost exclusively 
concomitant to or after RYGB to reduce pouch ex-
tensibility. Apart from vagotomy as intraoperative 
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complication, it has little influence on stool consistency, 
and when, patients rather tend to constipation[14].
BOWEL HABIT CHANGES AFTER 
BARIATRIC SURGERY
There is a consistent relationship between obesity and 
diarrhea[19]. The incidence of diarrhea in a preoperative 
bariatric population is around 8%[20], being twice 
as high as in lean people. A possible reason for this 
might be a higher intake of poorly absorbed sugars[21]. 
Indeed, digestive symptoms in general, including 
diarrhea, are frequent among obese patients, both 
before and after bariatric surgery[22,23].
There is a change of bowel habits after every 
bariatric procedure, even though the severity of sym-
ptoms differs between the individual techniques. Up to 
75% of patients suffer from alterations of bowel habits 
and faecal transit time after RYGB[20]. Diarrhea is a 
common symptom after RYGB[6,20,24], and usual after 
BPD[14,25]. Length of the common channel, i.e., the 
amount of absorptive surface, seems to play a role, 
given the higher frequency of diarrhea in long limb/
distal RYGB patients than after short limb/proximal 
RYGB procedures[26], in BPD compared to RYGB[25], and 
in BPD patients with shorter common channels[27].
SHORT BOWEL SYNDROME
Short bowel syndrome, defined by lack of absorptive 
surface, occurs in around 4% of patients after 
bariatric surgery[28]. The reported average small 
bowel length in obese patients ranges from 300 to 
900 cm, with considerable variability between 230 cm 
and 1510 cm[29-31]. However, there is a remarkable 
intra- and interoperator variability when it comes 
to determination of bowel length, both in open and 
laparoscopic procedures[32,33]. In the most commonly 
performed technique, the proximal RYGB, only the 
lengths of the alimentary (AL) and the biliopancreatic 
limbs (BPL) are defined and counted through, whereas 
the common channel remains of variable, unknown 
size. While AL of 100-150 cm and BPL of 45-85 cm are 
commonly used[30,34,35], there is ongoing debate about 
the delineation of optimal limb lengths. Nonetheless, 
this debate does not respect absorptive capacity of 
small bowel and even less its adaptation over time. 
Even though there is considerable progress in assessing 
intestinal malabsorption, no direct test with sufficient 
sensitivity and specificity is currently available, not 
to mention the diagnostic issues due to the altered 
anatomy after RYGB[36]. Initial treatment consists of 
supportive measures; surgical options are lengthening 
of the common channel, enteral nutrition via gastro-
stomy into the gastric remnant, and restitution of 
normal anatomy if still possible[37]. In the United States, 
6.3% of home parenteral nutrition patients have a 
history of bariatric surgery and over two-thirds of them 
underwent RYGB[38].
MALABSORPTION OF CARBOHYDRATES 
(LACTOSE, FRUCTOSE)
Carbohydrates were propagated in a low-fat diet for 
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figure 1  Laparoscopic sleeve gastrectomy. The greater curve of the 
stomach is resected alongside a bougie.
figure 2  Proximal Roux-Y gastric bypass. The stomach is divided to 
form a small gastric pouch. Alimentary Roux-Y limbs of up to 150 cm and 
a biliopancreatic limbs of around 50 cm are formed; the resulting common 
channel is of various length depending on length of the whole small bowel.
figure 3  Distal Roux-Y gastric bypass. The same principles as in proximal 
RYGB are applied; however, the length of the common channel, mostly around 
100 cm, is the determined factor and the alimentary limb is of variable length. 
RYGB: Distal Roux-Y gastric bypass.
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together with parenteral feeding, akin to World Health 
Organization Treatment guidelines for children[53]. 
Alternatively, surgical measures, such as limb length 
reshaping and reversal of RYGB, may be considered.
ENDOCRINE DISORDERS
Endocrine causes for diarrhea are rather related to 
morbid obesity and its comorbidities than to bariatric 
surgery. Ninety percent of patients with type 2 diabetes 
mellitus (T2DM) are overweight or obese[54]. Metabolic/
bariatric surgery, mainly RYGB, is gaining importance 
in the treatment of T2DM[4,55]. However, minimally sym-
ptomatic patients with T2DM may become symptomatic 
after RYGB. Furthermore, depending on preoperative 
duration and severity of T2DM, the relapse rate after 
a disease-free postoperative interval is reported to be 
up to 11%[56]. Several factors have an influence on 
diarrhea in T2DM-patients: dietetic, sugar-free food, 
association of T2DM to celiac disease[57], and T2DM-
induced disturbance of the enteric nerve system 
leading to altered gut motility, again resulting in SIBO 
and exocrine pancreatic insufficiency (EPI). 
Loss of weight and fat volume after bariatric 
surgery[58] may require adaptation of drug apportioning 
otherwise leading to postoperative overdosage, e.g., of 
thyroid hormones. Thus, switch from LSG to LRYGB for 
gastroesophageal reflux disease requires monitoring 
despite absent weight change, as L-thyroxine is 
absorbed in the (partly excluded) small bowel[59].
MICROBIOTA AND SIBO
In human adults, the gut microbiota is a complex and 
dynamic ecosystem that coevolves with its host[60], and 
remains remarkably constant slightly fluctuating around 
an individual core of stable colonisers. Low diversity of 
an individual’s fecal bacteria is associated with a more 
pronounced overall obesity and dyslipidemia, impaired 
glucose homeostasis, and considerable low-grade 
inflammation[61]. Dietary changes, use of proton pump 
inhibitors or (recurrent as well as short- and long-
term) antibiotic treatments may result in transient 
alterations of the gut microbiota composition[62,63]. 
It is still a matter of debate whether dietary intake 
or host genetics exert the stronger influence on 
microbial composition[64]. Not only development of 
obesity but also body weight reduction following 
bariatric surgery is, at least partly, attributed to 
alterations in gut microbiota. RYGB, as against SG, 
was demonstrated to substantially diminish the 
diversity of gut microbiota[65] paralleled by an increase 
in the proportion of Gammaproteobacteria and a 
decrease in Clostridia[66,67]. SG, however, was shown 
to cause a change in the Bacteroidetes/Firmicutes 
ratio, indeed, with a distinct increase in Bacteroidetes 
and a decline in the abundance of Firmicutes[68]. While 
the exact mechanisms remain unclear, change of the 
individual’s microbiota composition is considered to be 
years; they have a good palatability and are readily 
available in a high-caloric liquid form[39]. Liquids transit 
rapidly through the intestine and produce lesser satiety 
than the solid form. Sugar-sweetened beverages have a 
considerable impact on body weight, and there is clear 
association between their consumption and weight 
gain[40,41].
Even though a diet with a moderate amount of 
carbohydrates is recommended after bariatric sur-
gery[42], the proportion of ingested macronutrients - 
lipids, proteins and carbohydrates - remains constant, 
whereas the overall energy intake that is reduced[18]. 
Lack of the enzyme lactase in the intestinal mucosa 
leads to lactose malabsorption and intolerance with 
diarrhea. While symptoms are dependent on small 
bowel transit time, there is a poor correlation between 
lactose malabsorption and intolerance[18,43]. Lactase 
activity is diminished progressively in adulthood[44], 
and the influence of bariatric surgery on this process in 
unclear[6]. Furthermore, there is no data on symptoms 
after bariatric surgery in a population of non-Western 
European heritage, i.e., with a higher prevalence of 
lactase deficiency. On the other hand, a Scandinavian 
study found a lactose intolerance rate of 30% after 
jejuno-ileal bypass[45].
Fructose as monosaccharide is widely used as a 
sweetener in fat-reduced, low-caloric food. In contrast 
to the disaccharide form, its glucose-independent 
absorption capacity is limited[46]. Hydrogen breath 
tests can be used in the diagnosis of carbohydrate 
malabsorption. However, 18% of patients of European 
descent are hydrogen non-excretors resulting in a 
possible false-negative result. Furthermore, the effect 
of excluded small bowel segments on the test accuracy 
has not yet been elucidated. Abstaining from or at 
least reducing lactose and fructose in meals might be 
most productive for both diagnosis and therapy, even 
though enzyme replacement therapies, as referred to 
as lactase and xylose isomerase, are available[18]. 
PROTEIN-LOSING ENTEROPATHY
Micronutrients are absorbed in the mid to distal jeju-
num[47]. BPD-DS and to a lesser extent distal RYGB 
exclude these segments and are associated with 
macro- and micronutrient deficiencies[9,48]. Hypoalbu-
minemia occurs in up to 18% of BPD-DS patients[49], 
further aggravated by a protein intake of half of the 
recommended amount of 60-120 g protein daily in 
bariatric patients[47,50]. Hypoalbuminemia is associated 
with severe diarrhea in every fourth patient ending 
up with the need for parenteral nutrition[51]. The 
associated pathogenesis resembles the Kwashiorkor-
type malabsorption of severely undernourished children 
resulting in a reduced production of gastric acid, 
pancreatic atrophy, small intestinal bowel overgrowth 
(SIBO) and alterations of the gut microbiota[52]. 
Treatment is usually initiated by employing supportive 
measures, rehydration and volume replacement, 
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a key factor of postoperative body weight reduction 
and may be one of the potential contributors to a 
stable weight loss after bariatric surgery[65,69]. Even 
though one would assume the importance of the 
microbiome regarding occurrence and/or resolution of 
diarrhea after bariatric surgery, this has not yet been 
elucidated. Bacteroides, normally increased after SG, 
was found to be substantially decreased in patients 
with idiopathic chronic diarrhea[70]. These results were 
confirmed by another group reporting an enrichment 
of Bacteroides, among other phyla, in controls when 
compared to diarrhea cases, irrespective of whether 
they were or not Clostridium difficile-associated[71]. 
These results cast a possible relationship between the 
normally observed post-bariatric shift of Bacteroides 
within the microbiota composition and diarrhea into 
doubt. Further studies addressing this question are 
warranted. 
SIBO, defined as an excessive amount of bacteria 
in the small bowel[72], has a prevalence of 2.5% in 
healthy subjects[73], and up to 41% in obese patients, 
probably due to an impaired small intestinal motility[74]. 
In fact, side-side anastomoses with longer blind ends 
such as in candy cane syndrome are susceptible to 
SIBO[75,76]. A Brazilian group described a frequent 
occurrence of bacterial overgrowth in both the gastric 
pouch and the gastric remnant after RYGB in morbidly 
obese subjects, when assessed after a mean follow-
up of 7.3 years[77]. These patients, however, did 
not complain of consistent or prolonged symptoms 
suggestive of SIBO, namely diarrhea, malabsorption, 
abdominal pain, intestinal obstruction, or extradigestive 
complaints (polyarthritis, dermatologic abnormalities, 
progressive liver insufficiency), after a mean follow-up 
of almost 15 years[78]. Another group reported a more 
than two-fold rise of SIBO after RYGB. Yet, weight 
loss itself does not seem to favor SIBO, given the 
comparable rate of bacterial overgrowth before and 
after exclusively restrictive surgery, such as AGB[23]. 
The influence of proton pump inhibitors, caloric intake 
and dietary composition is another topic of debate[23,79]. 
Diagnostic insecurities and a high prevalence of SIBO 
complicate the exact determination of its effects. In 
fact, it was shown that two thirds of patients after 
RYGB had digestive symptoms, but none of those were 
more frequent in patients with SIBO[23]. Consequences 
of SIBO after bariatric surgery are unclear. The 
nutrients escaping digestion in the small bowel due 
to SIBO might yield elevated levels of short- and 
medium-chain fatty acids through metabolization in 
the large bowel, implying a higher caloric uptake[80,81]. 
However, data on expected resulting reduced weight 
loss is conflicting[23,82]. The altered anatomy with 
excluded small bowel segments severely inflicts 
diagnostic measures; aspiration and culture might be 
impossible despite advanced endoscopic techniques, 
and breath testing underlies the same restrictions[83].
CLOSTRIDIUM DIFFICILE
Alteration of gastrointestinal climate caused by 
obesity, antibiotic therapy or surgery is a risk factor 
for clostridium-associated colitis[84], even though 
it may occur in absence of the aforementioned 
factors[23]. Furthermore, it may present as a protein-
losing enteropathy with hypoalbuminemia without 
fulminant inflammation[85]. Individual types of stool 
tests can yield the diagnosis. However, the high rate 
of asymptomatic carriers demands for a combination 
of symptoms and positive test results[84]. Treatment 
aims at reestablishing a diverse microbial flora. 
Long-standing medical wisdom suggested treatment 
with only oral antibiotics, metronidazole rather than 
vancomycin, and avoiding antimotility agents such as 
loperamid. The latter lacks substantive data[86]; the 
former must be questioned, at least in post-RYGB and 
-BPD-patients. In view of the anatomic alterations 
after bariatric surgery and given the pharmacokinetics 
of metronidazole - it is almost completely absorbed 
in the small bowel - intravenous vancomycine might 
the preferred primary treatment option[87,88]. Fecal 
microbiota transplantation is a novel method to treat 
recurrent infections, and has also gained interest in 
the bariatric community due to its effects on weight 
loss[89].
ADDICTIVE DISORDERS 
An “addiction-transfer” away from food may be an 
explanation for the increased number of impulse 
control disorders after bariatric surgery[90]; a quarter 
of the bariatric population has an eating disorder that 
impedes weight loss[91]. Amongst other substances, 
alcohol and nicotine both lead to diarrhea when con-
sumed in excessive amounts[92]. Several cohort studies 
showed increased risk for alcohol abuse after bariatric 
surgery[93], further complicated by a faster rise of 
blood alcohol concentration[94]. Preoperative history of 
substance misusage is associated with postoperative 
abuse, as for alcohol ranging up to 12%[95,96]. Further-
more, consumption of excessive amounts of (sugar-free) 
drops, sometimes with the purpose of covering halitosis, 
must be kept in mind.
VAGOTOMY
Vagotomy during RYGB can be performed either inten-
tionally to enhance weight loss via earlier satiety and 
lessened food intake[97,98], as esophageal lengthening 
procedure concomitant to hiatal hernia repair[99] or 
inadvertently as intraoperative complication due 
to the proximity of the vagal nerves to the gastric 
pouch[100]. Diarrhea occurs in around 10% of patients 
after truncal and to a lesser extent after more distal 
vagotomy; severe, debilitating diarrhea occurs in 
2%-3%[101]. Controversially, intentional vagotomy to 
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gain esophageal length in hiatal hernia repair did not 
lead to higher rates of side effects[98,99]. Reasons for 
postvagotomy diarrhea are not completely elucidated, 
a change of microbial climate by altered intestinal 
motility and gastric hypoacidity certainly plays a role[102]. 
Beneath the usual dietary modifications proposed for 
RYGB, bulking agents to decrease the water content 
of the stool should be introduced. A short-term trial 
with octreoid can be attempted, however, isolated 
postvagotomy diarrhea is less responsive than dumping 
syndrome. In severe cases, surgical options such as 
alteration of limb lengths or even reversal of RYGB 
should be discussed.
BILE ACID MALABSORPTION
The role of bile acids in morbid obesity, its comorbidity 
and weight loss in post-bariatric patients experiences 
increased interest, as they seem to be profoundly 
involved in the postoperative metabolic improvement. 
The target of interest are FX- and TGR5-receptors 
and their influence on bile acid metabolism with sub-
sequently increased hormonal - in particular incretine - 
answer and change of gut microbiota[103,104]. 
Bile acid malabsorption results from a disturbed 
enterohepatic cycle and bile acid production. About 
95% of bile acids are reabsorbed in the ileum, an 
additional small percentage is absorbed in the colon 
with bowel motility, medication, microbiota and food 
composition as influencing factors[105-107]. FXR is 
involved in the regulation of bile acid production, in 
entero- and hepatocytes[108]. BAM is categorized as 
either idiopathic, secondary to ileal dysfunction, such 
as after resection, or unrelated to ileal dysfunction, 
mainly due to SIBO or cholecystectomy. A disturbed 
synthesis in idiopathic BAM might also play role in 
irritable bowel syndrome (IBS)-D patients, same as in 
post-cholecystectomy patients[109]. Cholecystectomy 
concomitant to a bariatric procedure was a standard 
of care in the last decades[110]. BAM might further be a 
cause for post-vagotomy diarrhea[102]. The short common 
channel after BPD and distal RYGB predisposes to BAM 
due to reduced reabsorption rate and diminished time for 
bile acids to exert its effects on digestion. So far, there 
is no data about the rate of BAM stratified for subtypes 
of bariatric procedures. Bile acid malabsorption can 
be detected by fecal bile acid quantification, radio-
labelled Selenium homotaurocholic acid testing or 
determination of serum-C4-concentration[111]; however, 
they all are expensive, rather difficult to apply in 
clinical practice or not standardized. Cholestyramine, 
a bile-acid binder, is an effective treatment with an 
efficacy up to 96%[112]. Due to the downsides of the 
above-mentioned testing procedures, it is used in 
diagnosis in an empirical trial[12].
EXOCRINE PANCREATIC INSUFFICIENCY
Gastrectomy and RYGB both can lead to secondary 
EPI resulting in steatorrhea[34,113] with subsequent 
deficiencies of fat-soluble vitamins. Depending on 
type of RYGB, proximal or distal, the prevalence of 
EPI is up to 19%-48% respectively[34]. Changes in 
caloric content, composition and physical properties of 
meals after RYGB lead to a diminished, uncoordinated 
pancreatic response to nutrient stimuli[114]. The altered 
anatomy after RYGB leads to a shorter amount of 
contact time of enzymes with chyme. In addition, the 
degradation of pancreatic enzymes is accelerated in 
absence of food in the biliopancreatic limb[114]. In rare 
cases, left pancreatic resection for dumping syndrome 
or nesidioblastosis is performed, leading to primary 
endocrine and EPI[115]. Testing for EPI proves difficult 
due to altered anatomy. Direct stimulation tests 
require the the intubation of the duodenum either in 
a transgastric way or via a double-balloon technique 
and measure the exocrine pancreatic response after 
stimulation with CCK or secretin. Indirect stimulation 
test, such as measurement of fecal fat or elastase-1 
are cheaper, more readily available but pose other 
problems. The former requires the ingestion of a 
defined amount of fat, which proves difficult after 
RYGB-induced, altered perception of food. In the 
latter, a normal result does not preclude EPI, as 
only the released amount of enzymes, but not its 
effect on chyme is measured; the shortened contact 
time within the common channel is not reflected. 
The recommended high-fat diet, based on lipids as 
strongest stimulators of exocrine pancreatic response, 
is hard to apply in post-RYGB patients[34]. Pancreatic 
enzyme replacement therapy is the mainstay of EPI 
treatment. Substitution is adapted to symptoms[114]; 
if using pancrealipase, removing the acid-resistant 
coating is imperative as the amount of produced acid 
in the gastric pouch is only minimal[34]. 
DUMPING SYNDROME
Diarrhea is one of many abdominal and systemic 
symptoms of mostly early dumping syndrome (DS), 
caused by a rapid exposure of the small bowel with 
undigested nutrients. Prevalence of DS after RYGB is 
reported to be up to 75%, and after SG up to 45%. 
Even though bothersome at least, DS is seen not 
seen as complication but rather as desirable feature 
by a few surgeons[116], it is thought to be an essential 
component of postoperative weight loss. Diagnosis 
relies mainly on symptom-based questionnaires like 
Sigstad’s scoring system, together with an oral glucose 
tolerance test or a mixed-meal test. However, those 
tests have a high sensitivity, but low specificity and 
are complicated by the small gastric pouch[117]. First-
line treatment of DS is directed at a change of diet 
towards a more fibre- and protein-rich regimen with 
a low proportion of rapid-absorbable carbohydrates. 
Dietary supplements such as pectin or glucomannan 
have a poor tolerability and may interfere with a 
post-bariatric diet[117]. Acarbose affects mainly late 
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DS, whilst diarrhea is associated rather with early 
DS. Somatostatin analogues are effective treatment 
options for both early and late DS, however, the have 
diarrhea as common side effect. Total parenteral 
nutrition is less practical, but sometimes inevitable 
option, other surgical possibilities consist in either 
remnant gastrostomy, reversal of RYGB or measure 
to enhance restriction of the pouch, such as AGB or 
pouch reshapings, only in very rare cases pancreatic 
resection have to be performed[118,119].
UNMASKED UNDERLYING INTESTINAL 
DISEASES
Inflammatory bowel disease
The cardinal symptom of both, Crohn’s disease and 
ulcerative colitis is diarrhea. It is unclear whether obesity 
and the subsequent proinflammatory state have a role 
in the pathogenesis of Crohn’s disease[120]. Even though 
bariatric surgery leads to a normalization of this state, 
bacterial overgrowth might lead to a local activation 
of innate immune factors favoring inflammation[121]. 
Whether bariatric surgery is of benefit remains to be 
elucidated, case series show a favorable outcome 
with LSG as procedure of choice[122-126]. Even though 
in most instances inflammatory bowel disease will 
be known prior to surgery, it might be missed in pre-
operative evaluation as it might occur later or is not 
captured, as morbid obesity seems to be associated 
with more colonic disease[127]. Of note, fecal calprotectin 
as measure for tissue inflammation is elevated after 
bariatric surgery[128].
Celiac disease
Approximately 40% of patients suffering from celiac 
disease (CD), traditionally associated with malab-
sorption and insufficient body weight, are overweight 
or obese at diagnosis[129,130]. They, therefore, could be 
potential candidates for bariatric surgery. Diarrhea is 
classically the hallmark of symptomatic coeliac disease. 
However, a trend toward silent or atypical forms has 
been observed[131]. Triggers including pregnancy, 
traveller’s diarrhea, gastroenteritis, and some type of 
gastrointestinal surgery were reported[132]. Indeed, a 
recent publication described the rapid onset of CD after 
bariatric surgery, i.e., a duodenal switch procedure[133]. 
After all, CD should be considered as a differential 
diagnosis in patients presenting with persistent diarrhea 
after bariatric surgery.
A group of Italian surgeons suggested a preopera-
tive work-up of specific CD tests (anti-endomysial 
and antitransglutaminase antibodies and total Immu-
noglobulin A) before bariatric procedures. Diagnosis 
of CD, consisting of harvesting duodenal biopsies is 
hindered after RGB due to the anatomical changes 
involved. In these cases, exlusively serologic testing 
remains an option. Indeed, a negative CD specific 
serology does not completely exclude the diagnosis 
of CD though it does make it much less likely[134]. The 
standard treatment of CD implementing a gluten-free 
diet (GFD) was shown to be successful in bariatric 
patients, either. In this line, a complete restoration of 
the intestinal muscosa within 12 mo after starting GFD 
was observed in a young adult with an incidentally 
diagnosed silent form of CD after bariatric surgery 
(vertical banded gastroplasty) 5 years earlier[135]. 
However, apart form a few case reports, little is known 
about onset, course, diagnosis and management 
of CD following bariatric surgery, particularly sleeve 
gastrectomy and RGB. 
IBS
A prevalence of up to 30% of IBS fulfilling the 
ROME Ⅲ criteria among morbidly obese patients 
was reported. These patients are more likely to 
suffer from profound alterations to quality of life and 
severe psychological disturbances than those without 
IBS[136,137]. On the other hand, a recent study of a large 
cohort showed that obesity is protective of a diagnosis 
or worsening of IBS[138]. Visceral adiposity, rather 
than general obesity, has been associated with an 
increased risk of diarrhea dominant IBS[139]. However, 
the association between the two entities remains 
unclear[140]. Increase of intra-abdominal pressure 
owing to excess of visceral fat, local tissue as well as 
systemic inflammation mediated by adipokines and 
cytokines originating from abdominal adipocytes[141-143], 
and altered gut microbiota[144] have been suggested 
as possible mechanisms that link obesity and IBS. 
Bariatric surgery, i.e., RGB, may improve the IBS 
symptoms[137]. Yet, the impact of bariatric surgery 
on visceral hypersensitivity and outcome of IBS is 
still unknown. Nevertheless, it might be advisable to 
systematically screen IBS and other functional bowel 
disorders in patients eligible for bariatric surgery.
CONCLUSION
There are a multitude of reasons for diarrhea in post-
bariatric patients. Diagnosis can be challenging, 
as they are often intertwined and the influence of 
inconsistent, mood-dependent elements, must not be 
underestimated. The special anatomy after RYGB and 
BPD with excluded bowel segments complicates testing 
and the interpretation of results. Thus, empiric therapy 
of limited time will help in diagnosis and treatment. 
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